172 related articles for article (PubMed ID: 3700283)
1. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
Rolston KV; LeBlanc B; Ho DH
J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
[TBL] [Abstract][Full Text] [Related]
2. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
Barlam T; Neu HC
Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
Soussy CJ; Leclercq R; Duval J
Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.
Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 1997 May; 41(5):1196-202. PubMed ID: 9145901
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of RU-66647, a new ketolide.
Jones RN; Biedenbach DJ
Diagn Microbiol Infect Dis; 1997; 27(1-2):7-12. PubMed ID: 9127099
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.
Benson CA; Segreti J; Beaudette FE; Hines DW; Goodman LJ; Kaplan RL; Trenholme GM
Antimicrob Agents Chemother; 1987 Feb; 31(2):328-30. PubMed ID: 2952063
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.
Rolston KV; Ho DH; LeBlanc B; Bodey GP
Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):30-3. PubMed ID: 2137413
[TBL] [Abstract][Full Text] [Related]
9. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
King A; Phillips I
Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
[TBL] [Abstract][Full Text] [Related]
10. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
Westerman EL; Williams TW; Moreland N
Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
[TBL] [Abstract][Full Text] [Related]
12. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of midecamycin, a new macrolide antibiotic.
Neu HC
Antimicrob Agents Chemother; 1983 Sep; 24(3):443-4. PubMed ID: 6639001
[TBL] [Abstract][Full Text] [Related]
14. Josamycin: interpretation of inhibition zones with the Bauer-Kirby agar disk diffusion test as compared with erythromycin.
Karthein J; Spohr M; Traub WH
Chemotherapy; 1986; 32(4):336-43. PubMed ID: 3731919
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of LY281389 and comparison with erythromycin and oral beta-lactams.
Qadri SM; Ueno Y; Frayha HH
Chemotherapy; 1991; 37(4):270-4. PubMed ID: 1790725
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of rokitamycin compared with that of other macrolides.
Yu KW; Briones F; Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
[TBL] [Abstract][Full Text] [Related]
17. Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
Eliopoulos GM; Reiszner E; Ferraro MJ; Moellering RC
J Antimicrob Chemother; 1987 Nov; 20(5):671-5. PubMed ID: 2962974
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
Brumfitt W; Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():29-37. PubMed ID: 1399948
[TBL] [Abstract][Full Text] [Related]
19. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
Dibb WL; Ragnhildstveit E
NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
[TBL] [Abstract][Full Text] [Related]
20. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Clin Microbiol; 1986 Aug; 24(2):233-9. PubMed ID: 3091634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]